Treating TB: What needs to be done to improve treatment rates

July 1, 2013

People with tuberculosis (TB) in China often delay going to see a doctor for more than two weeks, finds research in BioMed Central's open access journal BMC Medicine. Reasons for this include a poor understanding of TB, increasing costs of treatment not covered by health insurance, and using traditional approaches first. Even after going to a clinic there were still delays in treatment, especially in rural areas, due to a lack of qualified medical staff.

Worldwide TB remains a leading cause of death, and China has the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR) strains per countries. Delay in being treated increases the risk of spreading TB, and contributes to the development of MDR-TB. To reduce these risks it is important to understand why delays occur.

This meta-analysis of behaviour in seeking diagnosis and treatment for TB included almost 40,000 patients. Patients who delayed going to see a doctor by more than two weeks were more likely to live in rural areas, to be less educated or female. Poverty, lack of health insurance, rising costs of excess payments or treatments not covered by the insurance, as well as a poor understanding of TB were cited by patients in contributing to their delay in seeing a doctor. What seems to happen is that people would first try traditional Chinese medicine, as this was also a risk factor for delay.

Rural patients were also more likely to be subject to delays due to limited resources at the health care facility, such as a lack of qualified or ability to do appropriate tests.

Prof Shenglan Tang, from Duke University, and Dr Ying Li, from the Third Military Medical University, who carried out this study explained, "Inadequate and late detection of TB remains a challenge especially in rural China. By understanding the reasons behind this we can try to begin to change programs to ensure that these problems are addressed. There is also a stigma associated with TB which needs to be removed by better health promotion and by empowering individuals with TB to change how others view this disease."

Explore further: Still long delays in diagnosing TB and HIV

More information: Factors Associated with Patient, and Diagnostic Delays in Chinese TB Patients: A Systematic Review and Meta-analysis Ying Li, John Ehiri, Shenglan Tang, Daikun Li, YongqiaoBian, Hui Lin, Caitlin Marshall and Jia Cao BMC Medicine 2013, 11:156, www.biomedcentral.com/1741-7015/11/156

Related Stories

Still long delays in diagnosing TB and HIV

May 31, 2013
It still takes a long time for TB and HIV patients in Uganda to be properly diagnosed. As a result, many patients are infectious without knowing it themselves. These diagnostic delays, and also adherence to therapy, can be ...

China faces 'serious' epidemic of drug-resistant TB (Update)

June 6, 2012
China faces a "serious epidemic" of drug-resistant tuberculosis according to the first-ever nationwide estimate of the size of the problem there, said a US-published study on Wednesday.

Management of TB cases falls short of international standards

February 9, 2012
The management of tuberculosis cases in the European Union (EU) is not meeting international standards, according to new research.

New tuberculosis research movement needed

November 30, 2011
In this week's PLoS Medicine, Christian Lienhardt from the WHO in Geneva, Switzerland and colleagues announce that the Stop TB Partnership and the WHO Stop TB Department have launched the TB Research Movement.

Study finds vitamin C can kill drug-resistant TB (w/ video)

May 21, 2013
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...

Recommended for you

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.